Human TH17 cell development requires processing of dendritic cell–derived CXCL8 by neutrophil elastase - 06/06/18
Doi : 10.1016/j.jaci.2018.01.003
Yuri Souwer, PhD a, ∗, Tom Groot Kormelink, PhD b, ∗, Esther W. Taanman-Kueter, BSc b, Femke J. Muller, BSc a, Toni M.M. van Capel, BSc b, Domonkos V. Varga, MSc a, Yotam E. Bar-Ephraim, PhD a, Marcel B.M. Teunissen, PhD c, S. Marieke van Ham, PhD d, Taco W. Kuijpers, MD, PhD e, f, Diana Wouters, PhD d, Linde Meyaard, PhD g, Esther C. de Jong, PhD b 
a Department of Cell Biology & Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
b Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
c Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
d Department of Immunopathology, Sanquin Blood Supply and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
e Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
f Department of Blood Cell Research, Sanquin Blood Supply and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
g Laboratory of Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
| This work was supported by grants from the Landsteiner Foundation for Blood Research (LSBR, grant no. 0816), the Dutch Technology Foundation STW (grant no. 10725), and Netherlands Organization for Scientific Research (NWO) Vici (grant no. 91815608). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Vol 141 - N° 6
P. 2286 - juin 2018 Retour au numéro
Article précédent
- Role of local CpG DNA methylation in mediating the 17q21 asthma susceptibility gasdermin B (GSDMB)/ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3) expression quantitative trait locus
- Parul H. Kothari, Weiliang Qiu, Damien C. Croteau-Chonka, Fernando D. Martinez, Andrew H. Liu, Robert F. Lemanske, Carole Ober, Jerry A. Krishnan, Dan L. Nicolae, Kathleen C. Barnes, Stephanie J. London, Albino Barraza-Villarreal, Steven R. White, Edward T. Naureckas, Joshua Millstein, W. James Gauderman, Frank D. Gilliland, Vincent J. Carey, Scott T. Weiss, Benjamin A. Raby, Asthma BioRepository for Integrative Genomic Exploration (Asthma BRIDGE) Consortium
- Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion
- Malte Lenders, Boris Schmitz, Stefan-Martin Brand, Dirk Foell, Eva Brand
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?